Guangdong Cellwise Microelectronics Co. Ltd.
Guangdong Cellwise Microelectronics Co., Ltd. engages in the research, development, and sale of analog chips in the People's Republic of China. The company's products portfolio includes battery management chips, battery safety chips, battery metering chips, charging management, and other chips, as well as fuel gauge, power management IC, USB port charging controller, and brushed DC motor smart co… Read more
Guangdong Cellwise Microelectronics Co. Ltd. (688325) - Total Liabilities
Latest total liabilities as of June 2025: CN¥215.84 Million CNY
Based on the latest financial reports, Guangdong Cellwise Microelectronics Co. Ltd. (688325) has total liabilities worth CN¥215.84 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Guangdong Cellwise Microelectronics Co. Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how Guangdong Cellwise Microelectronics Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Guangdong Cellwise Microelectronics Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Guangdong Cellwise Microelectronics Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cullinan Oncology LLC
NASDAQ:CGEM
|
USA | $32.76 Million |
|
Naruida Technology Co. Ltd. Cl A
SHG:688522
|
China | CN¥280.70 Million |
|
KWS SAAT SE & Co. KGaA
PINK:KNKZF
|
USA | $1.12 Billion |
|
Boozt AB (publ)
PINK:BZTAF
|
USA | $2.91 Billion |
|
Sturm Ruger & Company Inc
NYSE:RGR
|
USA | $62.69 Million |
|
Ardagh Metal Packaging SA
NYSE:AMBP
|
USA | $5.79 Billion |
|
Beijing Beilu Pharmaceutical
SHE:300016
|
China | CN¥852.80 Million |
|
Daewoong Pharma
KO:069620
|
Korea | ₩1.26 Trillion |
Liability Composition Analysis (2019–2024)
This chart breaks down Guangdong Cellwise Microelectronics Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Cellwise Microelectronics Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Cellwise Microelectronics Co. Ltd. (2019–2024)
The table below shows the annual total liabilities of Guangdong Cellwise Microelectronics Co. Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥70.68 Million | +1.34% |
| 2023-12-31 | CN¥69.75 Million | +24.52% |
| 2022-12-31 | CN¥56.01 Million | -18.66% |
| 2021-12-31 | CN¥68.86 Million | +57.54% |
| 2020-12-31 | CN¥43.71 Million | +150.34% |
| 2019-12-31 | CN¥17.46 Million | -- |